心不全の末期期の高齢患者の代謝プロフィールの特定
Yukari Okuma1, Koji Yoshie1, Sho Suzuki1
1Department of Cardiovascular Medicine, Shinshu University School of Medicine.
まとめ
メタボロミクスは心臓不全の重要なバイオマーカーを特定した. カーニチン,尿素,対称性ダイメチルルギニンは死亡率と相関し,トリプトファンは生存率を示し,HFの早期発見と治療を助けます.
科学分野:
- 生物化学
- 心血管医学
- バイオマーカーの発見
背景:
- 心不全 (HF) は 人口の高齢化による医療上の課題です
- HFの早期発見は,患者のアウトカムと緩和ケアを改善することができます.
- メタボロミクスは,HFバイオマーカーを特定し,治療戦略を精製するための有望なアプローチを提供します.
研究 の 目的:
- 心不全の予後に関連したバイオマーカーを特定するメタボロミクスプロファイルの有用性を調査する.
- 特定の代謝産物と急性無補償性心不全患者の短期/長期の死亡率との相関を調査する.
主な方法:
- CURE-HFのレジストリを遡って分析した.
- 28人の急性無補償性心不全患者の血清サンプルを,毛細血管電泳飛行時間質量スペクトロメトリを用いて分析した.
- 代謝産物と生存結果の相関を特定するために,部分最小二乗 (PLS) 差別分析を使用した.
主要な成果:
- カーニチンは短期死亡率と負の相関関係を示した (R=0. 508,P=0. 006).
- 尿素 (R=- 0. 597,P< 0. 001) と対称性ダイメチルルギニン (R=- 0. 634,P< 0. 001) は生存率と負の相関関係を示した.
- トリプトファンは生存率と正の相関を示した (R=0. 548,P=0. 003).
結論:
- カーニチン,対称性ダイメチルルギニン,尿素,トリプトファンは,心不全の末期をモニタリングするための重要なバイオマーカーとして特定されています.
- この発見は,心筋のエネルギー代謝,腎機能障害,およびHF患者の観察された代謝変化との関連を示唆しています.
さらに関連する動画
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
4.0K
11:02Identification and Quantification of Deranged Metabolites in Critically Ill Patients Using NMR-Based Metabolomics
Published on: November 29, 2024
643
関連する概念動画
01:18Metabolic States of the Body: The Postabsorptive State
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...